TY - GEN
T1 - Mapping the transmural scar and activation for patients with ventricular arrhythmia
AU - Wang, Linwei
AU - Dawoud, Fady
AU - Wong, Ken C.L.
AU - Zhang, Heye
AU - Liu, Huafeng
AU - Sapp, John
AU - Horáček, Milan
AU - Shi, Pengcheng
PY - 2011
Y1 - 2011
N2 - Myocardial scar is the most common substrate for malignant arrhythmia and cardiac arrest. Radiofrequency ablation, as one of the emerging mainstream therapies, currently relies on electrophysiologic (EP) map acquired on endocardial and occasionally epicardial surfaces. As myocardial scar is often complex with shapes varying with the depth of the myocardium, endocardial and epicardial maps may differ substantially, and may fail to identify mid-wall fibrosis that exist in ∼ 30% of patients with nonischemic cardiomyopathy. Alternative image-based delineation of anatomical scar is noninvasive and transmural, but it does not reflect the possibly EP functional anomaly. In this paper, we present a validation study of a previously developed method that combines body-surface electrocardiographic data and image-derived anatomic data to compute EP and scar details along the depth of the myocardium. Experiments were performed on 4 patients referred for ablation associated with myocardial infarction, with gold standards of substrate voltage maps and activation maps acquired by CARTO electroanatomic mapping system. This study exhibits the ability of the presented method in accurately quantifying the scar substrate and capturing abnormal EP patterns, not only on the heart surfaces but along the transmural dimension.
AB - Myocardial scar is the most common substrate for malignant arrhythmia and cardiac arrest. Radiofrequency ablation, as one of the emerging mainstream therapies, currently relies on electrophysiologic (EP) map acquired on endocardial and occasionally epicardial surfaces. As myocardial scar is often complex with shapes varying with the depth of the myocardium, endocardial and epicardial maps may differ substantially, and may fail to identify mid-wall fibrosis that exist in ∼ 30% of patients with nonischemic cardiomyopathy. Alternative image-based delineation of anatomical scar is noninvasive and transmural, but it does not reflect the possibly EP functional anomaly. In this paper, we present a validation study of a previously developed method that combines body-surface electrocardiographic data and image-derived anatomic data to compute EP and scar details along the depth of the myocardium. Experiments were performed on 4 patients referred for ablation associated with myocardial infarction, with gold standards of substrate voltage maps and activation maps acquired by CARTO electroanatomic mapping system. This study exhibits the ability of the presented method in accurately quantifying the scar substrate and capturing abnormal EP patterns, not only on the heart surfaces but along the transmural dimension.
UR - http://www.scopus.com/inward/record.url?scp=84859960950&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84859960950&partnerID=8YFLogxK
M3 - Conference contribution
AN - SCOPUS:84859960950
SN - 9781457706127
T3 - Computing in Cardiology
SP - 849
EP - 852
BT - Computing in Cardiology 2011, CinC 2011
T2 - Computing in Cardiology 2011, CinC 2011
Y2 - 18 September 2011 through 21 September 2011
ER -